Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Cotellic?

See the DrugPatentWatch profile for Cotellic

Cotellic is the U.S. brand name for the drug tolvaptan. It belongs to the class of drugs known as vasopressin V2‑receptor antagonists (sometimes called “vaptans”). Below is a concise overview of what Cotellic is, how it’s used, and what you should know about it. This is general information; it is not a substitute for medical advice from a qualified clinician.


1. What Is Cotellic?

Item Details
Generic name Tolvaptan
Drug class Vasopressin V2‑receptor antagonist
Mechanism of action Blocks V2 receptors on kidney collecting ducts → inhibits water reabsorption → increases free water excretion (“aquaresis”)
Brand names Cotellic (ADPKD) / Samsca (hyponatremia) in the U.S.
Approved indications in the U.S. • Autosomal dominant polycystic kidney disease (ADPKD) – to slow decline in kidney function
• Hyponatremia due to SIADH (syndrome of inappropriate antidiuretic hormone) in adults with euvolemic or hypervolemic hyponatremia

2. How is Cotellic Used?

Condition Typical starting dose Titration Typical maintenance dose Duration
ADPKD 5 mg orally once daily Increase to 15 mg after 6–12 weeks if tolerated 15 mg once daily (some patients may stay at 5 mg) Long‑term (months–years) with periodic monitoring
SIADH‑related hyponatremia 15 mg once daily May increase to 30 mg once daily if sodium response is inadequate and tolerated 15–30 mg once daily Short‑term; usually discontinued once sodium normalizes or if adverse effects develop

Note: For both uses, the drug is taken once daily in the morning. It is usually taken on an empty stomach (30 min before or 2 h after a meal).


3. Why Is It Useful?

  1. ADPKD – The disease is characterized by fluid‑filled cysts that grow and compress healthy kidney tissue. Tolvaptan slows cyst growth and preserves kidney function, delaying the need for dialysis or transplant.
  2. Hyponatremia – By promoting free‑water excretion, tolvaptan raises serum sodium levels in patients whose low sodium is driven by excessive antidiuretic hormone action.

4. What Are the Common Side Effects?

Category Typical Symptoms
Water‑balance issues Thirst, dry mouth, polyuria (excessive urination), nocturia, “puffy” hands and feet
Gastro‑intestinal Nausea, abdominal discomfort, constipation, diarrhea
Central nervous system Headache, fatigue, dizziness
Liver Elevated transaminases (AST/ALT), jaundice (rare but serious)
Other Hyperuricemia, mild elevation of creatinine, mild blood pressure changes

Severe but rare: Acute liver injury (often reversible after drug discontinuation) and very high liver enzyme elevations (≥5× upper limit of normal).


5. Contraindications & Precautions

Issue Why It Matters
Severe hepatic impairment Tolvaptan is hepatically metabolized; liver disease increases risk of hepatotoxicity.
Pregnancy / breastfeeding Animal studies show fetal harm; no adequate human safety data.
Pregnancy category X Contraindicated.
Active liver disease Must be monitored closely; dose adjustments or discontinuation may be needed.
Severe renal impairment Caution; drug is primarily excreted by the kidneys; dose adjustment or avoidance may be necessary.
Concurrent use of potent CYP3A4 inhibitors or inducers Alters tolvaptan levels; may increase toxicity or reduce efficacy.

6. Drug Interactions

Interacting Drug Effect on Tolvaptan What to Do
Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, ritonavir) ↑ Tolvaptan concentration Avoid or lower dose
Strong CYP3A4 inducers (e.g., rifampin, carbamazepine, phenobarbital) ↓ Tolvaptan concentration Avoid or increase dose (often not recommended)
Medications causing hypovolemia (diuretics, NSAIDs) ↑ risk of electrolyte imbalance Monitor fluid status
Other drugs affecting serum sodium (e.g., lithium, NSAIDs) Possible additive effect on sodium Monitor serum sodium frequently

7. Monitoring Requirements

Parameter Frequency Why It Matters
Serum sodium Every 2–4 days initially, then weekly/biweekly Detect hyponatremia or over‑correction
Liver function tests (AST, ALT, bilirubin) Every 2–4 weeks for first 6 months, then quarterly Detect hepatotoxicity early
Kidney function (creatinine, eGFR) Every 2–4 weeks initially, then monthly Ensure no worsening renal impairment
Urine output Daily (patient logs) Detect excessive diuresis
Blood pressure & pulse Routine clinic visits Monitor for hypotension or tachycardia
Serum potassium & uric acid Every 4–6 weeks Monitor for hyperuricemia and hypokalemia

If liver enzymes rise >5× ULN, discontinue immediately.
If serum sodium rises >10 mEq/L in 24 h, reduce dose or pause therapy.


8. How to Take It

  1. Timing – Take the capsule once daily in the morning.
  2. Food – Best on an empty stomach.
  3. Hydration – Do not drink excessive water; the drug encourages water loss.
  4. Missed dose – Skip and resume next day; do not double dose.

9. What to Watch For (Signs of Serious Problems)

  • Persistent or worsening jaundice, dark urine, or fatigue → possible liver injury.
  • Rapid increase in serum sodium (>12 mEq/L in 24 h) → risk of osmotic demyelination; seek medical attention.
  • Severe dehydration or orthostatic dizziness.
  • Severe nausea/vomiting leading to inability to maintain hydration.

If you suspect any of these, contact your healthcare provider or go to an emergency department promptly.


10. Bottom Line

  • Cotellic (tolvaptan) is a powerful drug used mainly for ADPKD and, in some countries, for hyponatremia.
  • It works by increasing free‑water excretion, which can slow kidney disease progression and raise low sodium levels.


Other Questions About Cotellic :

Has roche lost exclusivity for cotellic in canada? Cotellic price? Cotellic cost? Cotellic manufacturer?